Kala制药(KALA)

5.43 %

今开:5.33昨收:5.27
最高:5.7最低:5.33
涨停价:跌停价:
总市值:350682785

Kala制药的热门评论

Takeabreak05-07 11:19

$Kala制药(KALA)$ 6刀5刀分别加了,浮亏较大。KPTI,BTAI,GTHX 也都不行,好在轻仓,确实只能是value play

美股市场有望回暖,这两只小摩所选股真能直冲云霄?

美股研究社04-15 17:24

本文作者:Marty Shtrubel 根据摩根大通首席执行官杰米•戴蒙(Jamie Dimon)的说法,美国正处于经济繁荣的风口浪尖,这种繁荣至少可以推动到2023年。戴蒙将强劲增长的前景归因于几个原因。 戴蒙表示:“我毫不怀疑,随着过度储蓄、新的刺激性储蓄、巨额赤字支出、更多的量化宽松政策、新的潜在基础...

Takeabreak04-09 23:44

$Kala制药(KALA)$ KALA Kala Pharmaceuticals risk/reward 'highly favorable,' says JPMorgan JPMorgan analyst Christopher Neyor reiterates an Overweight rating on Kala Pharmaceuticals with a $17 price target after meeting with management. The analyst sees a "highly f...

Takeabreak03-16 23:21

$Kala制药(KALA)$ “We are pleased to announce the addition of EYSUVIS to Cigna’s preferred formulary, reflecting a significant expansion of our commercial coverage and important progress toward our goal of securing broad patient access,” said Todd Bazemore, Chief Operating...

Kala制药的最新评论

壹电报实时快讯社群05-06 23:20

【 “牛市女皇”旗下ARKK重挫4.6%,生物科技股全线下跌 】 “牛市女皇”Cathie Wood旗下旗舰基金创新ETF-ARK重挫4.6%,为连续第八日下跌,本周迄今跌近12%。 美股生物制药股全线下跌,Kala制药跌超14%,Arbutus生物制药跌9%,脉冲生物科学跌近9%,Abeona Therapeutics跌超8%,太平洋生物科学跌超6...查看全文

Kala制药的公告

$Kala制药(KALA)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001558370-21-004991 Act: 34 Size: 300 KB 网页链接

$Kala制药(KALA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000947871-21-000277 Act: 34 Size: 83 KB 网页链接

$Kala制药(KALA)$ 内部交易: 2021-02-25,Chief Scientific Officer,Chen Hongming ,期权,47000普通股, $2.30